Invention Grant
- Patent Title: Azaadamantane formate ester and process for preparing azaadamantane derivatives
-
Application No.: US14622657Application Date: 2015-02-13
-
Publication No.: US09359356B2Publication Date: 2016-06-07
- Inventor: Albert Wayne Kruger , Shuang Chen , Steven Cramer Cullen , James Joseph Napier
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agent Portia Chen
- Main IPC: C07D221/22
- IPC: C07D221/22 ; C07D471/18 ; C07D285/12 ; C07D285/135 ; C07C249/02

Abstract:
A compound, (4s)-1-azaadamantane-4yl formate ester, is described. In addition, a process is described for preparing (4s)-1-azaadamantane-4yl formate ester, aminothiadiazole-phenyl phosphate salt, bromothiadizole-phenyl or (4s)-4-(5-phenyl-1,3,4-thiadiazol-2-yloxy)-1-azatricyclo[3.3.1.13,7]-decane dihydrogen citrate. Furthermore, a process is described, comprising step of hydrolyzing (4s)-1-azaadamantane-4yl formate ester to form (4s)-1-azaadamantan-4-ol HBr salt.
Public/Granted literature
- US20150166541A1 AZAADAMANTANE FORMATE ESTER AND PROCESS FOR PREPARING AZAADAMANTANE DERIVATIVES Public/Granted day:2015-06-18
Information query